PBS Pricing

Weighted Average Monthly Treatment Cost (WAMTC) User's Manual and Calculator

The Weighted Average Monthly Treatment Cost (WAMTC) methodology is a type of reference pricing applied to particular groups of Pharmaceutical Benefits Scheme (PBS) subsidised drugs.

The Weighted Average Monthly Treatment Cost (WAMTC) methodology is a type of reference pricing applied to particular groups of Pharmaceutical Benefits Scheme (PBS) subsidised drugs.
Further information about the pricing of Pharmaceuticals and the Pharmaceutical Benefit's Pricing Authority is available in the Authorities Manual :

"Policies, Procedures and Methods used in the Pricing of Pharmaceutical Products".

WAMTC User's Manual (PDF 872 KB)

WAMTC Calculator (Excel 300 KB)


PLEASE NOTE:

The WAMTC User’s Manual will be updated in 2010, as the April 2009 Manual does not reflect:

1. Recent formation of four new therapeutic groups:

a. Statins-HP group (2009-2010 Budget measure, commenced on 1 September 2009)

b. Venlafaxine group and Bisphosphonates osteoporosis and Paget disease groups (commenced on 21 January 2010; and

2. The 2009 2010 Budget Measure which provides for application of PBS reference pricing policies to all brands of non-exempt pharmaceutical items. Exemptions from WAMTC are affected by this policy.

Please contact the Pharmaceutical Benefits Pricing Authority (PBPA) Secretariat if you have any enquiries related to these matters.

Secretary
PBPA
Pricing Section
Ph: 02 6289 7779
Email: pbspricing@health.gov.au
Top of page